Babar Bashir

18PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 01, 2026
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.

|May 26, 2026
In-Use Stability and Device Compatibility Define Clinically Actionable Handling Limits for a GMP-Produced Attenuated Listeria monocytogenes Vaccine Expressing GUCY2C.

|Nov 03, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.

David H Aggen, Meredith McKean, Jean H Hoffman-Censits

|Jul 29, 2025
Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer.

Matthew Bloom, Ali Raza Shaikh, Zhengyang Sun

|Sep 04, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

Babar Bashir, Judy S Wang, Gerald Falchook

|Feb 23, 2024
Immunotherapy resistance in solid tumors: mechanisms and potential solutions.

Daniel S Lefler, Steven A Manobianco, Babar Bashir

Pageof 3

Frequent Collaborators

6 joint publications

Adam E Snook

4 joint publications

Daniel S Lefler

2 joint publications

Meredith McKean

2 joint publications

Sanjay Mishra